Literature DB >> 238280

Antibacterial precipitins and autoantibodies in serum of patients with cystic fibrosis.

N Høiby, A Wiik.   

Abstract

Sera from 84 patients with cystic fibrosis, 31 patients with other respiratory diseases and 21 control persons have been investigated for the occurrence of antibacterial precipitins and autoantibodies. Preciptins were studied by means of crossed immunoelectrophoresis, antinuclear factors by an indirect immunofluorescence technique and rheumatoid factors by the latex fixation slide test. A very heterogeneous antibacterial immune response was found in patients with cystic fibrosis, notably as regards Ps. aeruginosa. None of the other patients or controls had precipitins against this bacterium. The occurrence of precipitins against St. aureus and D. pneumoniae were more frequent in cystic fibrosis patients as compared with controls, but not as compared with other respiratory disease patients. No significant differences were found as regards precipitins against H. influenzae or the occurrence of rheumatoid factors. Antinuclear factors were more frequent in cystic fibrosis patients than in the other two groups investigated. A pronounced and heterogeneous humoral immune response against Ps. aeruginosa in cystic fibrosis patients chronically infected with mucoid strains of this bacterium was found to be correlated with poor prognosis and the reason for this is discussed.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 238280

Source DB:  PubMed          Journal:  Scand J Respir Dis        ISSN: 0036-5572


  11 in total

Review 1.  Cystic fibrosis. Infection and immunity to Staphylococcus aureus and Haemophilus influenzae.

Authors:  D P Greenberg; H R Stutman
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

Review 2.  Pathogenesis and management of arthropathy in cystic fibrosis.

Authors:  B M Phillips; T J David
Journal:  J R Soc Med       Date:  1986       Impact factor: 5.344

3.  HLA type, islet cell antibodies, and glucose intolerance in cystic fibrosis.

Authors:  P R Stutchfield; S M O'Halloran; C S Smith; J C Woodrow; G F Bottazzo; D Heaf
Journal:  Arch Dis Child       Date:  1988-10       Impact factor: 3.791

4.  Diagnostic and prognostic value of serum antibodies against Pseudomonas aeruginosa in cystic fibrosis.

Authors:  M Kappler; A Kraxner; D Reinhardt; B Ganster; M Griese; T Lang
Journal:  Thorax       Date:  2006-01-31       Impact factor: 9.139

5.  Serum IgG antibodies in patients with cystic fibrosis with early Pseudomonas aeruginosa infection.

Authors:  M M Brett; A T Ghoneim; J M Littlewood
Journal:  Arch Dis Child       Date:  1987-04       Impact factor: 3.791

6.  Sequential studies of lymphocyte responsiveness and antibody formation in acute bacterial meningitis.

Authors:  V Andersen; N E Hansen; H Karle; I Lind; N Hoiby; B Weeke
Journal:  Clin Exp Immunol       Date:  1976-12       Impact factor: 4.330

7.  Immune responses to liver membrane antigens in patients with cystic fibrosis and liver disease.

Authors:  G Mieli-Vergani; H T Psacharopoulos; A M Nicholson; A L Eddleston; A P Mowat; R Williams
Journal:  Arch Dis Child       Date:  1980-09       Impact factor: 3.791

8.  Cellular immunity to bacteria: impairment of in vitro lymphocyte responses to Pseudomonas aeruginosa in cystic fibrosis patients.

Authors:  R U Sorensen; R C Stern; S H Polmar
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

9.  Isolation and characterization of circulating immune complexes in cystic fibrosis.

Authors:  R B Moss; Y P Hsu
Journal:  Clin Exp Immunol       Date:  1982-02       Impact factor: 4.330

10.  Protective immunization against chronic Pseudomonas aeruginosa pulmonary infection in rats.

Authors:  J D Klinger; H A Cash; R E Wood; J J Miler
Journal:  Infect Immun       Date:  1983-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.